Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Researchers use gene therapy to cure obesity and type 2 diabetes in mice

A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

9 Jul 2018

Survival mechanisms of polar fish inspire revolutionary method to 'freeze' bacteria

The survival mechanisms of polar fish have led scientists at the University of Warwick to develop of a revolutionary approach to 'freeze' bacteria.

6 Jul 2018

Irregular metabolism of branched-chain amino acids may cause progression of type 2 diabetes

In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus, a temporary form of diabetes in which hormonal changes disrupt insulin function.

6 Jul 2018

Pregnant women with type 1 diabetes at increased risk of having babies with heart defects

Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.

5 Jul 2018

Women who work 45 hours or more per week show greater risk of diabetes

A new study has shown that women who work 45 hours or more per week are at an increased risk of diabetes, compared to those who work for 30-40 hours a week.

3 Jul 2018

Established lung fibrosis can be reversed using diabetes drug treatment

Researchers at the University of Alabama at Birmingham have shown -; for the first time -; that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.

2 Jul 2018

Duke Regional Hospital implements Glytec's eGMS to personalize insulin therapy

With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance with best practices is integral to safe, effective care and speedy recovery

30 Jun 2018

New study links air pollution to increased risk of diabetes globally

New research links outdoor air pollution -; even at levels deemed safe -; to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

30 Jun 2018

Researchers focus on delivery of insulin in pill form

One mother vividly remembers her three-and-a-half-year-old son's pleas when he received insulin injections several times each day. "He would beg and plead, 'Don't do it Momma!'" she recalls.

29 Jun 2018

Obesity together with aging may contribute to development of Alzheimer's disease

A new study suggests that when a high-fat, high-sugar diet that leads to obesity is paired with normal aging, it may contribute to the development of Alzheimer's disease.

29 Jun 2018

Mice study opens new avenues to develop therapies for growth disorders

Maintaining equal growth rates in opposing limbs is crucial for animals to achieve a symmetrical adult form; what happens if something goes wrong with one limb during development?

27 Jun 2018

Human insulin as safe and effective as expensive insulin analogs for patients with type 2 diabetes

Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according to a study by Yale School of Medicine researchers and colleagues at Kaiser Permanente.

27 Jun 2018

New approach needed to treat type 2 diabetes in youth

A major study has found that medicines used to treat diabetes in adults are not effective on youth. The researchers say the finding is disturbing because type 2 diabetes among youth is a growing problem.

27 Jun 2018

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Chemical compounds produced by the bacteria in our gut could be used to spot the early stages of liver disease, according to new research.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association meeting taking place this weekend in Orlando, Fla.

22 Jun 2018

New study reveals how ‘good’ bacteria help in regulating our metabolism

Research tells us that the commensal or "good" bacteria that inhabit our intestines help to regulate our metabolism.

22 Jun 2018

Research does not confirm antidiabetic action of natural fatty acid derivatives

A research consortium between the healthcare company Sanofi and Johannes Gutenberg University Mainz investigated the antidiabetic action of certain natural fatty acids, so-called FAHFAs, which US-American scientists had reported in 2014.

21 Jun 2018

FDA expands approval of novel diabetes management device to include younger pediatric patients

The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes.

21 Jun 2018

FDA approves Eversense CGM system for use in adults with diabetes

The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes.

21 Jun 2018

Insulin News and Research

Further Reading

Researchers use gene therapy to cure obesity and type 2 diabetes in mice

Survival mechanisms of polar fish inspire revolutionary method to 'freeze' bacteria

Irregular metabolism of branched-chain amino acids may cause progression of type 2 diabetes

Pregnant women with type 1 diabetes at increased risk of having babies with heart defects

Women who work 45 hours or more per week show greater risk of diabetes

Established lung fibrosis can be reversed using diabetes drug treatment

Duke Regional Hospital implements Glytec's eGMS to personalize insulin therapy

New study links air pollution to increased risk of diabetes globally

Researchers focus on delivery of insulin in pill form

Obesity together with aging may contribute to development of Alzheimer's disease

Mice study opens new avenues to develop therapies for growth disorders

Human insulin as safe and effective as expensive insulin analogs for patients with type 2 diabetes

New approach needed to treat type 2 diabetes in youth

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

New study reveals how ‘good’ bacteria help in regulating our metabolism

Research does not confirm antidiabetic action of natural fatty acid derivatives

FDA expands approval of novel diabetes management device to include younger pediatric patients

FDA approves Eversense CGM system for use in adults with diabetes

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News